<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ameyaw Elvis Ofori</style></author><author><style face="normal" font="default" size="100%">Woode Eric</style></author><author><style face="normal" font="default" size="100%">Kyei Samuel</style></author><author><style face="normal" font="default" size="100%">Biny Peter Robert</style></author><author><style face="normal" font="default" size="100%">Boampong Johnson Nyarko</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Anti-Nociceptive Synergism of Pregabalin and Xylopic acid Co-administration in Paclitaxel-induced Neuropathy: Isobolographic Analysis</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Isobolograms</style></keyword><keyword><style  face="normal" font="default" size="100%">Neuropathic pain</style></keyword><keyword><style  face="normal" font="default" size="100%">Paclitaxel</style></keyword><keyword><style  face="normal" font="default" size="100%">Toxicity.</style></keyword><keyword><style  face="normal" font="default" size="100%">xylopic acid</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">7th July 2015</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">7</style></volume><pages><style face="normal" font="default" size="100%">55-57</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Paclitaxel-induced neuropathy still remains a clinical problem for patients undergoing chemotherapy. &lt;strong&gt;Objective: &lt;/strong&gt;The objective of the study was to determine the interaction between xylopic acid and pregabalinco-administration as well as their toxicity in paclitaxel-induced neuropathy. &lt;strong&gt;Materials and Methods: &lt;/strong&gt;Neuropathic pain was induced in rats with 2 mg/kg of paclitaxel on alternative days for four days (days 0, 2, 4 and 6). Equi effective doses of xylopic acid and pregabalin that produced 50% anti-nociception (ED50) were determined from their log-dose response curves in the cold allodynia and thermal pain tests. Xylopic acid and pregabalin were again administered to rats in a fixed ratio combination (1:1) of their ED50&amp;rsquo;sin order to determine the experimental ED50 (Zexp) of the co-administered compounds. Isobolograms were constructed to compare the Zexp to a theoretical ED50 (Zadd). Blood samples from the various treatment groups of rats were collected for toxicological assessment of the co-administered compounds. &lt;strong&gt;Results:&lt;/strong&gt; The Zexplay below the Zadd on the isobologram of the cold allodnia test. The co-administration exhibited additivity in the thermal pain test. The co-administration did not produce significant (p&amp;gt;0.05) toxicity in rats. The co-administration may be beneficial in paclitaxel-induced neuropathy.&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Key words:&lt;/strong&gt; Isobolograms, Neuropathic pain, Paclitaxel, xylopic acid, Toxicity.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Ameyaw Elvis Ofori&lt;sup&gt;1*&lt;/sup&gt;, Woode Eric&lt;sup&gt;3&lt;/sup&gt;, Kyei Samuel&lt;sup&gt;2&lt;/sup&gt;, Biny Peter Robert&lt;sup&gt;3&lt;/sup&gt;, Boampong Johnson Nyarko&lt;sup&gt;1 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Biomedical and Forensic Sciences, School of Biological Sciences, College of Agriculture and Natural Sciences, University of Cape Coast, Cape Coast, Ghana.&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Optometry, School of Physical Sciences, College of Agriculture and Natural Sciences, University of Cape Coast, Cape Coast, Ghana.&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.&lt;/p&gt;</style></auth-address></record></records></xml>